Shinpoong Pharmaceutical Co Ltd (019175.KS) stock: key figures, P/E, revenue and dividend

Health Care · Pharmaceuticals · South Korea · ISIN KR7019171008

Price
13,300.00 KRW
Market cap
687.72 bn KRW
P/E (2025)
77.93
P/S (2025)
2.93
Dividend yield
0.00 %
Net margin
3.76 %
Return on equity (ROE)
3.27 %
Return on assets (ROA)
2.50 %

Shinpoong Pharmaceutical Co Ltd financials

Fiscal year20242025
Revenue221.09 bn KRW234.68 bn KRW
Gross profit81.80 bn KRW102.67 bn KRW
Operating income-17.03 bn KRW14.26 bn KRW
EBIT-11.99 bn KRW11.14 bn KRW
Net income-15.39 bn KRW8.83 bn KRW
Diluted EPS – continuing operations-312.30 KRW170.67 KRW

Full history since 2014, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Shinpoong Pharmaceutical Co Ltd

Shinpoong Pharmaceutical Co.,Ltd, together with its subsidiaries, manufactures and sells pharmaceutical products in South Korea. The company offers cephalosporin antibiotics; penicillin antibiotics; and finished products, as well as antivirals, anticancer drugs, painkillers, anti-inflammatory products, and anthelmintics. It provides active pharmaceutical ingredients; Pyramax, an anti-malarial drug; and drugs for treating hypercholesterolemia, knee osteoarthritis and shoulder periarthritis, and surgical adhesion barrier; prescription drugs; wound dressings; health functional food; and over the counter products. In addition, the company engages in business management and exports its products to approximately 50 countries. The company was founded in 1962 and is headquartered in Seoul, South Korea.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 11.11.2026. Details in the risk notice.